96 related articles for article (PubMed ID: 2162216)
1. Urokinase receptors in human monocytes.
Nykjaer A; Petersen CM; Christensen EI; Davidsen O; Gliemann J
Biochim Biophys Acta; 1990 May; 1052(3):399-407. PubMed ID: 2162216
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
[TBL] [Abstract][Full Text] [Related]
3. [Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration].
Arefieva TI; Krasnikova TL; Parfenova EV; Alekseeva IA
Biull Eksp Biol Med; 1998 Aug; 126(8):147-9. PubMed ID: 9777222
[No Abstract] [Full Text] [Related]
4. Cryptic urokinase binding sites on human foreskin fibroblasts.
Bajpai A; Baker JB
Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
[TBL] [Abstract][Full Text] [Related]
5. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
[TBL] [Abstract][Full Text] [Related]
6. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
Del Rosso M; Dini G; Fibbi G
Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
Ragno P; Montuori N; Rossi G
Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.
Jensen PH; Christensen EI; Ebbesen P; Gliemann J; Andreasen PA
Cell Regul; 1990 Dec; 1(13):1043-56. PubMed ID: 1966892
[TBL] [Abstract][Full Text] [Related]
9. Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.
Casslén B; Gustavsson B; Angelin B; Gåfvels M
Mol Hum Reprod; 1998 Jun; 4(6):585-93. PubMed ID: 9665342
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes.
Kirchheimer JC; Nong YH; Remold HG
J Immunol; 1988 Dec; 141(12):4229-34. PubMed ID: 2848891
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.
Felez J; Miles LA; Plescia J; Plow EF
J Cell Biol; 1990 Oct; 111(4):1673-83. PubMed ID: 2170426
[TBL] [Abstract][Full Text] [Related]
12. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
[TBL] [Abstract][Full Text] [Related]
13. Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.
Hollas W; Soravia E; Mazar A; Henkin J; Blasi F; Boyd D
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):629-34. PubMed ID: 1322138
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
15. Modulation of receptor bound urokinase-type plasminogen activator on human monocytes by non-steroidal antiinflammatory drugs.
Kirchheimer JC
Scand J Rheumatol; 1993; 22(2):53-7. PubMed ID: 8386851
[TBL] [Abstract][Full Text] [Related]
16. Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.
Jensen PH; Nykjaer A; Andreasen PA; Lund LR; Astedt B; Lecander I; Gliemann J
Biochim Biophys Acta; 1989 Nov; 986(1):135-40. PubMed ID: 2819091
[TBL] [Abstract][Full Text] [Related]
17. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
[TBL] [Abstract][Full Text] [Related]
18. Cellular receptor for urokinase-type plasminogen activator: protein structure.
Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
[No Abstract] [Full Text] [Related]
19. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Plow EF; Freaney DE; Plescia J; Miles LA
J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
[TBL] [Abstract][Full Text] [Related]
20. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
